IGF2BP2 and colorectal carcinoma: In our previous study, methyltransferase‐like 3 (METTL3) facilitated colorectal carcinoma (CRC) progression through increasing SOX2 expression to maintain the CRC stemness phenotype in an m6A‐IGF2BP2‐dependent machinery.24